The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group
Open accessAbstract
Angioedema is defined as localized and self‐limiting edema of the subcutaneous and submucosal tissue, due to a temporary increase in vascular permeability caused by the release of vasoactive mediator(s). When angioedema recurs without significant wheals, the patient should be diagnosed to have angioedema as a distinct disease. In the absence of accepted classification, different types of angioedema are not uniquely identified. For this reason, the E uropean A cademy of A llergy and C linical I mmunology gave its patronage to a consensus conference aimed at classifying angioedema. Four types of acquired and three types of hereditary angioedema were identified as separate forms from the analysis of the literature and were presented in detail at the meeting. Here, we summarize the analysis of the data and the resulting classification of angioedema.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biochemical abnormality in hereditary angioneurotic edema
Donaldson, V. H., & Evans, R. R. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90162-1 · Cited by 968
EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria
Zuberbier, T., Asero, R., Bindslev‐Jensen, C., Walter Canonica, G., Church, M. K., Giménez‐Arnau, A., Grattan, C. E. H., Kapp, A., Merk, H. F., Rogala, B., et al. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02179.x · Cited by 731
Plasma bradykinin in angio-oedema
Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., & Agostoni, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09137-x · Cited by 706
Self-citationAgostoni, A., Aygören-Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.047 · Cited by 646
Self-citationBowen, T., Cicardi, M., Farkas, H., Bork, K., Longhurst, H. J., Zuraw, B., Aygoeren-Pürsün, E., Craig, T., Binkley, K., Hebert, J., et al. (2010) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-6-24 · Cited by 614
Self-citationAGOSTONI, A., & CICARDI, M. (1992) · Medicine · doi:10.1097/00005792-199207000-00003 · Cited by 610
Self-citationTreatment of Hereditary Angioedema with Danazol: Reversal of Clinical and Biochemical Abnormalities
Gelfand, J. A., Sherins, R. J., Alling, D. W., & Frank, M. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197612232952602 · Cited by 607
Kostis, J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.09.014 · Cited by 579
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
Cicardi, M., Banerji, A., Bracho, F., Malbrán, A., Rosenkranz, B., Riedl, M., Bork, K., Lumry, W., Aberer, W., Bier, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906393 · Cited by 564
Self-citationHereditary angioedema with normal C1-inhibitor activity in women
Bork, K., Barnstedt, S.-E., Koch, P., & Traupe, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02483-1 · Cited by 557
Self-citation
Research works printed but not linked: 51
- Quinke H, 1882, Uber akutes umschriebened hautodem, Monatshe Prakt Dermatol, 1, 129
- 10.1111/j.1398-9995.2009.02234.x · doi:10.1111/j.1398-9995.2009.02234.x
- Colas C, 2012, Nonhistaminergic idiopathic angioedema: clinical response to icatibant, J Investig Allergol Clin Immunol, 22, 520
- 10.1016/j.anai.2012.03.013 · doi:10.1016/j.anai.2012.03.013
- 10.1016/j.ajem.2013.04.024 · doi:10.1016/j.ajem.2013.04.024
- Dobbels P, 2009, Acute abdomen due to intestinal angioedema induced by ACE inhibitors: not so rare?, Acta Gastroenterol Belg, 72, 455
- 10.1097/MCG.0b013e318299c69d · doi:10.1097/mcg.0b013e318299c69d
- 10.1007/s10875-012-9691-2 · doi:10.1007/s10875-012-9691-2
- 10.1016/S0022-2143(96)90083-9 · doi:10.1016/s0022-2143(96)90083-9
- Steinbach O, 2001, C1‐Esterase‐Inhibitor bei ACE‐Hemmer‐induziertem schwerem Angioodem der Zunge, Anaesthesiol Reanim, 26, 133
- 10.1097/00005537-200012000-00007 · doi:10.1097/00005537-200012000-00007
- Hauptmann G, 1979, Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy, Clin Exp Immunol, 37, 523
- 10.3324/haematol.10769 · doi:10.3324/haematol.10769
- 10.1172/JCI114084 · doi:10.1172/jci114084
- He S, 1996, Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 inhibitor deficiency, J Immunol, 156, 2009, 10.4049/jimmunol.156.5.2009 · doi:10.4049/jimmunol.156.5.2009
- Mandle R, 1994, Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor, J Immunol, 152, 4680, 10.4049/jimmunol.152.9.4680 · doi:10.4049/jimmunol.152.9.4680
- 10.1159/000018252 · doi:10.1159/000018252
- 10.2174/156652410791317066 · doi:10.2174/156652410791317066
- 10.1016/S0002-9343(03)00396-6 · doi:10.1016/s0002-9343(03)00396-6
- 10.1016/0091-6749(91)90248-M · doi:10.1016/0091-6749(91)90248-m
- Lam D, 2012, Acquired angioedema and marginal zone lymphoma, J Clin Oncol, 16, e551
- Ziakas PD, 2004, Acquired angioedema: a new target for rituximab?, Haematologica, 89, ELT13
- 10.1016/0091-6749(89)90082-1 · doi:10.1016/0091-6749(89)90082-1
- 10.1111/j.1365-2230.2010.03788.x · doi:10.1111/j.1365-2230.2010.03788.x
- 10.2340/00015555-1055 · doi:10.2340/00015555-1055
- 10.2500/aap.2013.34.3620 · doi:10.2500/aap.2013.34.3620
- 10.1016/j.jaci.2010.07.037 · doi:10.1016/j.jaci.2010.07.037
- 10.1016/j.jaci.2006.07.035 · doi:10.1016/j.jaci.2006.07.035
- 10.1016/j.jaci.2013.04.006 · doi:10.1016/j.jaci.2013.04.006
- 10.1016/S0161-5890(98)90835-5 · doi:10.1016/s0161-5890(98)90835-5
- 10.1002/humu.20112 · doi:10.1002/humu.20112
- 10.2500/aap.2010.31.3394 · doi:10.2500/aap.2010.31.3394
- 10.1111/j.1572-0241.2006.00492.x · doi:10.1111/j.1572-0241.2006.00492.x
- 10.1172/JCI105094 · doi:10.1172/jci105094
- 10.1016/j.jim.2008.06.004 · doi:10.1016/j.jim.2008.06.004
- 10.1111/j.1538-7836.2011.04455.x · doi:10.1111/j.1538-7836.2011.04455.x
- 10.1111/j.1365-2249.2007.03438.x · doi:10.1111/j.1365-2249.2007.03438.x
- 10.1136/jcp.55.2.145 · doi:10.1136/jcp.55.2.145
- Brecy H, 1975, Distinction between hereditary and acquired angioneurotic oedema according to the complement system, Biomedicine, 23, 328
- 10.1001/archderm.1975.01630210056003 · doi:10.1001/archderm.1975.01630210056003
- 10.1111/j.0954-6820.1972.tb04818.x · doi:10.1111/j.0954-6820.1972.tb04818.x
- 10.1056/NEJMoa0805538 · doi:10.1056/nejmoa0805538
- 10.1016/j.jaci.2009.07.017 · doi:10.1016/j.jaci.2009.07.017
- 10.1186/1710-1492-6-22 · doi:10.1186/1710-1492-6-22
- 10.1111/j.1398-9995.2010.02433.x · doi:10.1111/j.1398-9995.2010.02433.x
- 10.1016/j.tripleo.2011.02.034 · doi:10.1016/j.tripleo.2011.02.034
- 10.2500/aap.2012.33.3585 · doi:10.2500/aap.2012.33.3585
- 10.1111/j.1537-2995.2009.02394.x · doi:10.1111/j.1537-2995.2009.02394.x
- Cocchio C, 2009, Cinryze, a human plasma‐derived C1 esterase inhibitor for prophylaxis of hereditary angioedema, P T, 34, 293
- 10.1067/mai.2001.114242 · doi:10.1067/mai.2001.114242
- 10.1016/j.anai.2012.05.022 · doi:10.1016/j.anai.2012.05.022
Cited by
Maurer, M., Magerl, M., Betschel, S., Aberer, W., Ansotegui, I. J., Aygören‐Pürsün, E., Banerji, A., Bara, N., Boccon‐Gibod, I., Bork, K., et al. (2022) · Allergy · doi:10.1111/all.15214 · Cited by 534
Self-citationMaurer, M., Magerl, M., Ansotegui, I., Aygören‐Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A. S., et al. (2018) · Allergy · doi:10.1111/all.13384 · Cited by 513
Self-citationMutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema
Bafunno, V., Firinu, D., D'Apolito, M., Cordisco, G., Loffredo, S., Leccese, A., Bova, M., Barca, M. P., Santacroce, R., Cicardi, M., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.020 · Cited by 308
Self-citationCoagulation factor XII in thrombosis and inflammation
Maas, C., & Renné, T. (2018) · Blood · doi:10.1182/blood-2017-04-569111 · Cited by 255
Aygören-Pürsün, E., Magerl, M., Maetzel, A., & Maurer, M. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0815-5 · Cited by 169
Cilia La Corte, A. L., Carter, A. M., Rice, G. I., Duan, Q. L., Rouleau, G. A., Adam, A., Grant, P. J., & Hooper, N. M. (2011) · Human Mutation · doi:10.1002/humu.21579 · Cited by 154
The Expanding Spectrum of Mutations in Hereditary Angioedema
Veronez, C. L., Csuka, D., Sheikh, F. R., Zuraw, B. L., Farkas, H., & Bork, K. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2021.03.008 · Cited by 57
Self-citation
Metadata
- Authors
- Cicardi, M., Aberer, W., Banerji, A., Bas, M., Bernstein, J. A., Bork, K., Caballero, T., Farkas, H., Grumach, A., Kaplan, A. P., Riedl, M. A., Triggiani, M., Zanichelli, A., & Zuraw, B.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2014-03-27
- Volume
- 69
- Issue
- 5
- Pages
- 602-616
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2098192722
- Cited by
- 666
- References
- 105
- FWCI
- 31.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.